Evanthia Galanis Selected Research

Evanthia Galanis Research Topics

Disease

78	Neoplasms (Cancer) 02/2022 - 02/2002
41	Glioblastoma (Glioblastoma Multiforme) 02/2022 - 04/2005
23	Glioma (Gliomas) 02/2022 - 11/2004
15	Infections 12/2020 - 11/2003
13	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2006
10	Brain Neoplasms (Brain Tumor) 01/2022 - 02/2011
10	Measles 01/2021 - 08/2002
9	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 08/2002
8	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2009
5	Hematologic Neoplasms (Hematological Malignancy) 10/2018 - 08/2002
4	Oligodendroglioma 01/2022 - 07/2019
4	Melanoma (Melanoma, Malignant) 01/2017 - 02/2002
3	Triple Negative Breast Neoplasms 01/2021 - 09/2014
3	Astrocytoma (Pilocytic Astrocytoma) 07/2019 - 08/2014
3	Fatigue 01/2018 - 07/2009
3	Disease Progression 01/2018 - 04/2008
3	Multiple Myeloma 01/2018 - 07/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017 - 07/2009
3	Sarcoma (Soft Tissue Sarcoma) 01/2016 - 06/2002
3	Prostatic Neoplasms (Prostate Cancer) 12/2009 - 01/2009
2	Medulloblastoma 01/2022 - 11/2012
2	Thrombocytopenia (Thrombopenia) 01/2018 - 07/2009
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018 - 02/2002
2	Communicable Diseases (Infectious Diseases) 01/2016 - 10/2013
2	Chromosomal Instability (Chromosome Stability) 01/2015 - 09/2014
2	Inflammation (Inflammations) 10/2012 - 02/2011
2	Virus Diseases (Viral Diseases) 10/2012 - 10/2012
2	Pleural Effusion (Pleural Effusions) 06/2012 - 08/2010
1	Circulating Neoplastic Cells 01/2022

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 01/2022 - 08/2002
11	Proteins (Proteins, Gene)FDA Link 12/2020 - 12/2006
10	Pharmaceutical PreparationsIBA 11/2020 - 02/2002
9	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 10/2011
8	Bevacizumab (Avastin)FDA Link 01/2022 - 09/2009
6	Aurora Kinase AIBA 01/2021 - 05/2013
6	Carcinoembryonic AntigenIBA 01/2018 - 09/2006
5	sodium-iodide symporter (sodium iodide symporter)IBA 01/2018 - 12/2009
5	ErbB Receptors (EGF Receptor)IBA 12/2016 - 04/2005
4	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 02/2022 - 01/2016
4	AntigensIBA 01/2022 - 10/2012
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 02/2011
4	Vorinostat FDA Link 01/2018 - 04/2009
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016 - 04/2005
4	Phosphotransferases (Kinase)IBA 09/2014 - 08/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 09/2009
4	Antineoplastic Agents (Antineoplastics)IBA 09/2009 - 08/2002
3	RNA (Ribonucleic Acid)IBA 10/2018 - 10/2012
3	TOR Serine-Threonine KinasesIBA 01/2018 - 08/2005
3	Peptides (Polypeptides)IBA 01/2017 - 08/2002
3	LigandsIBA 01/2017 - 11/2004
3	Anticonvulsants (Antiepileptic Drugs)IBA 11/2015 - 10/2005
3	EnzymesIBA 11/2015 - 10/2005
3	Irinotecan (Camptosar)FDA LinkGeneric 11/2015 - 10/2003
3	Everolimus FDA Link 09/2015 - 06/2008
3	Interleukin-13IBA 04/2012 - 09/2008
3	Histone Deacetylase InhibitorsIBA 02/2012 - 04/2009
3	Green Fluorescent ProteinsIBA 10/2010 - 12/2006
3	epidermal growth factor receptor VIIIIBA 04/2007 - 12/2006
2	src-Family KinasesIBA 11/2019 - 01/2013
2	Dasatinib (BMS 354825)FDA Link 11/2019 - 01/2013
2	Imatinib Mesylate (Gleevec)FDA Link 07/2019 - 07/2019
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 09/2009
2	temsirolimus FDA Link 01/2018 - 08/2005
2	Estrogen Receptor alphaIBA 01/2018 - 01/2014
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 09/2013
2	Phenobarbital (Luminal)FDA Link 01/2018 - 09/2014
2	Biological ProductsIBA 01/2017 - 02/2010
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017 - 01/2017
2	PlatinumIBA 01/2015 - 02/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2015 - 02/2010
2	Hormones (Hormone)IBA 01/2014 - 06/2012
2	Antiviral Agents (Antivirals)IBA 04/2013 - 12/2009
2	AntibodiesIBA 03/2013 - 12/2009
2	Immunoglobulin G (IgG)IBA 03/2013 - 08/2009
2	Complement System Proteins (Complement)IBA 03/2013 - 07/2008
2	Virulence Factors (Pathogenicity Factors)IBA 10/2012 - 02/2011
2	Platinum Compounds (Compounds, Platinum)IBA 10/2012 - 10/2005
2	CytokinesIBA 06/2012 - 02/2011
2	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 04/2012 - 09/2008
2	Neutralizing AntibodiesIBA 02/2011 - 04/2003
2	Immunoglobulins (Immunoglobulin)IBA 08/2009 - 07/2008
2	dl1520 (ONYX-015)IBA 01/2009 - 04/2003
2	Gemcitabine FDA Link 05/2008 - 06/2002
2	DNA (Deoxyribonucleic Acid)IBA 12/2004 - 04/2003
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2022
1	Permethrin (Ambush)FDA LinkGeneric 01/2022
1	S-(beta-p-methoxypropiophenone)thiamine (MB 2)IBA 01/2022
1	carotuximabIBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	atezolizumabIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	FurinIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2021

Therapy/Procedure

41	Therapeutics 02/2022 - 08/2002
17	Radiotherapy 02/2022 - 12/2007
17	Drug Therapy (Chemotherapy) 01/2021 - 06/2002
12	Immunotherapy 01/2022 - 02/2002
4	Oncolytic Virotherapy 01/2019 - 01/2009
3	Intravenous Administration 10/2012 - 11/2003
2	Injections 01/2009 - 04/2005